The FDA released draft guidance intended to curb unnecessary animal testing in cancer drug development.
Former U.S. Attorney General Pam Bondi, 60, publicly disclosed her thyroid cancer diagnosis. (People)
Proposed work requirements for Medicaid recipients could markedly increase missed cancer screenings. (UChicago Medicine)
A circulating tumor DNA assay detected breast cancer recurrence risk over a year before conventional methods could identify relapse. (Lund University)
The expanding use of artificial intelligence in radiology may create new challenges to patient privacy. (Radiological Society of North America)
In an open letter to HHS Secretary Robert F. Kennedy Jr., sixty organizations representing cancer patients and survivors urged safeguards to preserve the integrity of the U.S. Preventive Services Task Force following the dismissal of key leaders by the Trump administration. (American Cancer Society)
The Oncology Institute, which operates 100 cancer clinics across five states, acknowledged a cybersecurity breach in which patient data was accessed by an unauthorized third party. (The HIPAA Journal)
Might bioengineered chewing gum contribute to the prevention of head and neck cancers? (WHYY)
Did the FDA or the European Medicines Agency’s Committee for Medicinal Products for Human Use reach the more accurate assessment of the oral breast cancer drug camizestrant? (Clinical Trial Vanguard)
AstraZeneca noted that the FDA has postponed a decision on camizestrant, pending further data review.